Back
Sprott Critical Materials ETF Vs. Cidara Therapeutics Industry Stock Comparison
Buy
72
SETM
Sprott Critical Materials ETF
Last Price:
$21.25
Seasonality Move:
8.67%
Buy
78
CDTX
Cidara Therapeutics
Last Price:
$63.02
Seasonality Move:
2.23%
Buy
72
Sprott Critical Materials ETF (SETM)
is a Buy
Is Sprott Critical Materials ETF a Buy, Sell or Hold?
-
The current Sprott Critical Materials ETF [SETM] share price is $21.32. The Score for SETM is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
SETM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $63.25. The Score for CDTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SETM Stock Price Chart
What is Sprott Critical Materials ETF's stock price today?
-
The Sprott Critical Materials ETF share price today is $21.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SETM is experiencing slight buying pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $63.25Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SETM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.58 | Buy |
Relative Strength Index (14 RSI): | 70.34 | Buy |
Chaikin Money Flow: | 39224 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 16.36 | Buy |
Relative Strength Index (14 RSI): | 68.7 | Buy |
Chaikin Money Flow: | 700144 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.5 - 64.06) | Buy |
Bollinger Bands (100): | (17.06 - 51.62) | Buy |
SETM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.06 | Buy |
20-day SMA: | 19.92 | Buy |
50-day SMA: | 18.24 | Buy |
200-day SMA: | 16.34 | Buy |
8-day EMA: | 19.11 | Buy |
20-day EMA: | 13.35 | Buy |
50-day EMA: | 7.06 | Buy |
200-day EMA: | 2.06 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.15 | Buy |
20-day SMA: | 61.7 | Buy |
50-day SMA: | 47.71 | Buy |
200-day SMA: | 27.34 | Buy |
8-day EMA: | 59.28 | Buy |
20-day EMA: | 43.54 | Buy |
50-day EMA: | 23.74 | Buy |
200-day EMA: | 7.04 | Buy |
Sprott Critical Materials ETF Earnings Growth & SETM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $4.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.92 per share, and a decrease next year of $1.83 per share.
Sprott Critical Materials ETF Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |